Comparing of effectiveness carbetocin and oxytocin in reducing bleeding due to child delivery.
- Conditions
- Health Condition 1: O720- Third-stage hemorrhage
- Registration Number
- CTRI/2022/10/046872
- Lead Sponsor
- Department of Obstetrics and Gynaecology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Age 18 and above
Women in early spontaneous labor
Women planned for cesarean section (ELECTIVE).
.Women undergoing emergency cesarean section in which oxytocin stopped for more than 1hour
Period of gestation < 28 weeks
Women undergoing labor induction or planned for induction
Underlying cardiovascular, autoimmune, hepatic, or renal disease,
Placenta accreta.
Known allergy to oxytocin or related product.
Patient on anticoagulation.
Patient not in a sound state to give consent(eclampsia, psychiatric disorders) and epilepsy disorder
Instrumental delivery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method